Literature DB >> 21541718

Off-label use of recombinant activated coagulation factor VII for bleeding may raise the risk of arterial thrombosis.

Laura Ferrari1, Gian Marco Podda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21541718     DOI： 10.1007/s11739-011-0593-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  2 in total

1.  A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes.

Authors:  Robert MacLaren; Laura A Weber; Helga Brake; Melinda A Gardner; Mario Tanzi
Journal:  Transfusion       Date:  2005-09       Impact factor: 3.157

2.  Safety of recombinant activated factor VII in randomized clinical trials.

Authors:  Marcel Levi; Jerrold H Levy; Henning Friis Andersen; David Truloff
Journal:  N Engl J Med       Date:  2010-11-04       Impact factor: 91.245
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.